Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention

doi:10.4251/wjgo.v12.i12.1381

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4608)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

203

WORD

HTML

2096

Figures (1-3)

164

Tables (1-3)

158

Sum=2715

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

578

Download

1315

Sum=1893

Dec 15, 2020 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Dec 15, 2020; 12(12): 1381-1393
Published online Dec 15, 2020. doi: 10.4251/wjgo.v12.i12.1381

Open in New Tab Full Size Figure Download Figure

Figure 1 Case selection flow chart for the one million nationwide representative database. ES: Endoscopic sphincterotomy; EPBD: Endoscopic papillary balloon dilatation; NHIRD: National Health Insurance Research Database.

Open in New Tab Full Size Figure Download Figure

Figure 2 Cholangiocarcinoma cases diagnosed during different follow-up periods in the endoscopic sphincterotomy/endoscopic papillary balloon dilatation group, endoscopic sphincterotomy/endoscopic papillary balloon dilatation and cholecystectomy group, no intervention group, and normal population. ES: Endoscopic sphincterotomy; EPBD: Endoscopic papillary balloon dilatation; CCY: Cholecystectomy.

Open in New Tab Full Size Figure Download Figure

Figure 3 Cumulative subsequent cholangiocarcinoma risk in the endoscopic sphincterotomy/endoscopic papillary balloon dilatation group, endoscopic sphincterotomy/endoscopic papillary balloon dilatation and cholecystectomy group, no intervention group, and normal population (The cases of cholangiocarcinoma within 18 mo after index admission were excluded). ES: Endoscopic sphincterotomy; EPBD: Endoscopic papillary balloon dilatation; CCY: Cholecystectomy.

Citation: Wang CC, Tseng MH, Wu SW, Yang TW, Chen HY, Sung WW, Su CC, Wang YT, Lin CC, Tsai MC. Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention. World J Gastrointest Oncol 2020; 12(12): 1381-1393
URL: https://www.wjgnet.com/1948-5204/full/v12/i12/1381.htm
DOI: https://dx.doi.org/10.4251/wjgo.v12.i12.1381